TL
Talis Biomedical Corporation
TLIS · OTC
$2.84 +0.00% (+$0.00)
Market Cap $5.18M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9Valuation
50 /100
Fair P/B 0.07x
P/S 12.57x
P/FFO N/A
Growth
0 /100
Declining Rev. growth 66.48%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 15,050.20%
Op. margin 16,217.20%
FCF margin 13,040.30%
Quality
0 /100
Poor ROA 65.50%
Asset turnover 0.00x
ROIC 75.26%
Debt
96 /100
Low Current ratio 8.86x
Net debt/EBITDA 0.86x
Debt/Equity 0.28x
Stability
61 /100
Moderate EPS volatility 7.03%
Profitable years 0
Beta 1.32x
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o TLIS
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Rebecca Markovich
Employees
99
Headquarters
Menlo Park